| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-08-06 | NCT07750665 FXS6837 for the Treatment for IgAN Patients（Longterm Study） | Phase 2 | Not Yet Recruiting |
| 2026-08-05 | NCT07747090 A Study of the Efficacy and Safety of FXS6837 Capsules Compared to Eculizumab for 24… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06569420 | Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and… | Non-Small Cell Lung Cancer | Active, Not Recruiting |
| NCT05913037 | FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related… | Neurofibromatosis 1 | Active, Not Recruiting |
| NCT07004075 | FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade… | Low-grade Glioma | Not Yet Recruiting |
| NCT07747090 | A Study of the Efficacy and Safety of FXS6837 Capsules Compared to Eculizumab for 24… | Paroxysmal Nocturnal Hemoglobinuria | Not Yet Recruiting |
| Phase 2 | |||
| NCT05997602 | To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients… | Langerhans Cell Histiocytosis | Recruiting |
| NCT07552012 | A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With… | Active Non-anterior, Non-infectious Uveitis | Recruiting |
| NCT06858618 | FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms | Safety | Active, Not Recruiting |
| NCT07502638 | FXS6837 for the Treatment of IgAN Patients | IgAN | Not Yet Recruiting |
| NCT07562581 | A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC | Non-small Cell Lung Caner | Not Yet Recruiting |
| NCT07750665 | FXS6837 for the Treatment for IgAN Patients（Longterm Study） | Primary IgAN | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT04954001 | Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of… | Neurofibromatosis 1 | Active, Not Recruiting |
| NCT07024394 | Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants… | Neurofibromatosis 1 | Not Yet Recruiting |
| Phase 1 | |||
| NCT07345637 | Phase I Study of FXS887 in the Treatment of Solid Tumors | Solid Tumor Refractory to Conventional Treatment | Not Yet Recruiting |
| NCT07558200 | Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors | Solid Tumors | Not Yet Recruiting |
| NCT07616089 | Phase I Study of FXS0683 in the Treatment of Blood Tumors | B-Cell Lymphoma | Not Yet Recruiting |
| NCT07695779 | QT Interval Effects Study of Oral FXS5626 Tablets | Evaluation of QTc Interval | Not Yet Recruiting |